---
document_datetime: 2023-09-21 20:35:29
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rekovelle-epar-all-authorised-presentations_en.pdf
document_name: rekovelle-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7709642
conversion_datetime: 2025-12-23 05:22:27.837436
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength        | Pharmaceutical Form    | Route of Administration   | Immediate Packaging    | Pack size                               |
|------------------|-------------------|-----------------|------------------------|---------------------------|------------------------|-----------------------------------------|
| EU/1/16/1150/004 | Rekovelle         | 12 µg / 0.36 ml | Solution for injection | Subcutaneous use          | pre-filled pen (glass) | 1 pre-filled pen + 3 injection needles  |
| EU/1/16/1150/005 | Rekovelle         | 36 µg / 1.08 ml | Solution for injection | Subcutaneous use          | pre-filled pen (glass) | 1 pre-filled pen + 9 injection needles  |
| EU/1/16/1150/006 | Rekovelle         | 72 µg / 2.16 ml | Solution for injection | Subcutaneous use          | pre-filled pen (glass) | 1 pre-filled pen + 15 injection needles |